TY - JOUR
T1 - Adenosine stimulation of Na+ transport is mediated by an A1 receptor and a [Ca2+]i-dependent mechanism
AU - Hayslett, John P.
AU - Macala, Lawrence J.
AU - Smallwood, Joan I.
AU - Kalghatgi, Leena
AU - Gasalla-Herraiz, Jose
AU - Isales, Carlos
N1 - Funding Information:
This study was supported by the National Institutes of Health grant DK 18061. Dr. Gasalla-Herraiz was supported by a grant from Fondo de Investigacion Sanitaria Ia Seguridad Social of Spain, and Dr. Isales was supported by Award DK-19813. The authors are grateful to M. Tara- gowski and M. Pucci for the preparation of the manuscript and figures.
Funding Information:
Reagents Arginine vasopressin (AVP), adenosine deaminase (ADA; Type V-bovine spleen), trifluoperazmne (TFP), 1,1,2-Trichiorotri-fluoroethane and tri-N-octylamine were obtained from Sigma (St. Louis, MO, USA). Additional chemicals were obtained from the following vendors: cyclohexyladenosine (CHA), Boehringer- Mannheim (Indianapolis, IN, USA); chelerythrine and forskolin (Calbiochem, La Jolla, CA, USA); 2',5' dideoxyadenosine (DDA) (Pharniacia, Milwaukee, WI, USA); 1,3-dipropyl-8-cyciopentylxan- thine (DPCPX) and CGS21680, RBI, (Natick, MA, USA); pertussis toxin, List Biologicals (Campbell, CA, USA); Ro-201724 (Biomol Research Lab, Inc. Plymouth Meeting, PA, USA); amiloride was a gift from Merck Sharp & Dohme Research Labs (Rahway, NJ, USA) and 7,8-dihydroxychiorpromazine was provided by Research Bio-chemical, Inc., as part of the Chemical Synthesis Program of the National Institute of Mental Health, Contract 278—90-007 (BS).
PY - 1995/6
Y1 - 1995/6
N2 - Studies were performed to determine the primary signal transduction mechanism that mediates adenosine stimulation of electrogenic sodium transport in renal epithelial cells. Experiments were performed on cultured amphibian A6 cells with an adenosine analogue that preferentially binds to the A1 receptor, cyclohexyladenosine (CHA). Sodium transport was assessed by the equivalent short circuit current (Ieq). CHA was found to stimulate Ieq via activation of an A1 receptor because (1) the threshold concentration was 1 nM compared to that of 10 μM for the specific A2 agonist CGS21680, (2) CHA inhibited vasopressin (AVP)-stimulated cAMP production by a pertussis toxin-sensitive mechanism, and (3) the action of CHA was inhibited by the A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). CHA increased intracellular Ca2+ ([Ca2+]i) and stimulated phosphoinositide turnover at concentrations that increased Ieq and in a time course that paralleled the increase in Ieq. Ion transport was stimulated by a Ca2+-dependent mechanism because the CHA induced increase in Ieq was inhibited by chelating [Ca2+]i with 5,5′dimethyl BAPTA in a dose-dependent manner, with a Ki of approximately 10 μM. The increase in Ieq was also dose-dependently inhibited by the specific PKC inhibitors dihydroxychlorpromazine and chelerythrine, and by trifluoperazine which inhibits PKC and calmodulin. Further studies indicated that CHA-stimulated Ieq was independent of cAMP generation because CHA did not induce an increase in cAMP accummulation parallel to the increase in Ieq in a dose-response analysis, and the adenylate cyclase inhibitor 2′,5′ dideoxy-adenosine (DDA) did not affect the CHA-induced increase in Ieq. These studies indicate, therefore, that adenosine stimulation of Ieq occurs, at least in part, through calcium-dependent signal transduction events and not through regulation of adenylate cyclase.
AB - Studies were performed to determine the primary signal transduction mechanism that mediates adenosine stimulation of electrogenic sodium transport in renal epithelial cells. Experiments were performed on cultured amphibian A6 cells with an adenosine analogue that preferentially binds to the A1 receptor, cyclohexyladenosine (CHA). Sodium transport was assessed by the equivalent short circuit current (Ieq). CHA was found to stimulate Ieq via activation of an A1 receptor because (1) the threshold concentration was 1 nM compared to that of 10 μM for the specific A2 agonist CGS21680, (2) CHA inhibited vasopressin (AVP)-stimulated cAMP production by a pertussis toxin-sensitive mechanism, and (3) the action of CHA was inhibited by the A1 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). CHA increased intracellular Ca2+ ([Ca2+]i) and stimulated phosphoinositide turnover at concentrations that increased Ieq and in a time course that paralleled the increase in Ieq. Ion transport was stimulated by a Ca2+-dependent mechanism because the CHA induced increase in Ieq was inhibited by chelating [Ca2+]i with 5,5′dimethyl BAPTA in a dose-dependent manner, with a Ki of approximately 10 μM. The increase in Ieq was also dose-dependently inhibited by the specific PKC inhibitors dihydroxychlorpromazine and chelerythrine, and by trifluoperazine which inhibits PKC and calmodulin. Further studies indicated that CHA-stimulated Ieq was independent of cAMP generation because CHA did not induce an increase in cAMP accummulation parallel to the increase in Ieq in a dose-response analysis, and the adenylate cyclase inhibitor 2′,5′ dideoxy-adenosine (DDA) did not affect the CHA-induced increase in Ieq. These studies indicate, therefore, that adenosine stimulation of Ieq occurs, at least in part, through calcium-dependent signal transduction events and not through regulation of adenylate cyclase.
UR - http://www.scopus.com/inward/record.url?scp=0028999197&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028999197&partnerID=8YFLogxK
U2 - 10.1038/ki.1995.221
DO - 10.1038/ki.1995.221
M3 - Article
C2 - 7643526
AN - SCOPUS:0028999197
SN - 0085-2538
VL - 47
SP - 1576
EP - 1584
JO - Kidney International
JF - Kidney International
IS - 6
ER -